Go to Page # Page of 156
loading

Solithromycin for The Treatment of Community-Acquired Bacterial Pneumonia (CABP)

 Prabhavathi Fernandes PhD
  27th-Dec-2016
Description: Solithromycin Proposed Indication (Oral and IV Formulation): - For the treatment of community-acquired bacterial pneumonia (CABP) caused by susceptible isolates of the following Gram-positive and Gram-negative bacteria: Streptococcus pneumoniae (including penicilin-resistant isolates, macrolide-resistant isolates, multi-drug-resistant isolates, and cases with concurrent bacteremia), Haemophilus influenzae (Includeing beta-lactamase producing isolates), Moraxella caterrhalis, Staphylococcus aureus (methicilin-susceptible [MSSA]), and the atypical bacterial pathogens Leionella pneumophila and Mycoplasma pneumoniae.
Views: 1105
Domain: Medical
Category: Biotech/Pharma
Contents:
BACK-UP SLIDES SHOWN
ONSCREEN

Recent Presentations

...
19 September, 2019
...
18 September, 2019
...
17 September, 2019